Rashmi Pershad

Research Manager Department of Physical Medicine and Rehabilitation Carolinas Rehabilitation
Prior Positions and Experience

2009–Present
Research Manager, Carolinas Rehabilitation

2006–2009
Assistant Director Dept. of Physical Medicine and Rehabilitation Research

2002–2005
Genome Facility Manager/ Co-Director of NCI Shared Resource Facility-M.D. Anderson Cancer Center Houston Texas

1999–2002
Research Scientist-M.D. Anderson Cancer Center Houston Texas

1998–2002
Research Coordinator- M.D. Anderson Cancer Center Houston Texas

Education

M Phil: 1994, University of Central Lancashire, Preston, England
BSc:
1987, University College London, England

Research Interests

Rashmi Pershad has 20 years of experience in research and research administration, from working as a bench scientist, early in her career to managing a multicenter research grant $2,500,000. From 1993- 2005, she worked at M.D Anderson Cancer Center in Houston Texas, where she ran and expanded the DNA Analysis Facility, providing over 80 investigators with the latest DNA sequencing and genomic analysis services. This facility was supported by an NCI core grant and reviewers recognized the facility as outstanding for its rigorous requirements and high quality data that resulted in over 60 publications in leading journals and led to successful application for refunding in 2003.

In 2006, Rashmi Pershad assumed the position of Assistant Director of the Research at Carolinas Rehabilitation and expanded her experience to traumatic brain injury and spinal cord injury. She managed several NIDRR and one NIH research project, over saw staff and ensured both project timelines and deliverables were met. In 2009, she became the Research Manager for the department of Physical Medicine and is currently, co-investigator on several research studies that look at combining interest in traumatic brain injury with that of biomarker research.

Recent Publications

Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchunk A, Gray JW, Hogg D, Bast RC, Jr. and Yu Y. ARHI is the center of Allelic Deletion on Chromosome 1p31 in Ovarian and Breast Cancers. Int. J. Cancer 2000: 86, 690-694. [PMID 10797292] 

Luo RZ, Peng H, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC Jr. and Yu Y. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARH1 Biochim Biophys Acta 2001 1519(3): 216-222. [PMID 11418188] 

Mu X, Zhao, S, Pershad R, Tzung-Fu Hsieh, Scarpa A, Wang SW, White A, Beremand PD, Thomas TL, Gan L and Klein HW. Gene expression in the developing mouse retina by EST sequencing and microarray analysis. Nucleic Acids Research, 2001, Vol. 29, No.24 4983-4993. [PMID PMC97568

Weil MM, Pershad R, Wang R and Zhao S. Use of BAC end sequences for SNP discovery. In: S. Zhao and M. Stodolsky (eds.), Bacterial Artificial Chromosomes: Methods and Protocols. Humana Press.2002. 

Weil MM, Pershad R, Wang R, Zhao S. Methods Molecular Biology Use of BAC end sequences for SNP Discovery.  2004: 256:1-6. [PMID 15024155] 

Wiebe GJ, Pershad R, Escobar H, Hawes JW, Hunter T, Jackson-Machelski E, Knudtson KL, Robertson M and Thannhauser TW. DNA Sequencing Research Group (DSRG) 2003 - A general survey of core DNA sequencing facilities. Journal of Biomolecular Techniques 2003. 14(3), 231-235. PMCID [PMC2279958] 

Mu X, Beremand P, Zhao S, Pershad R, Sun H, Scarpa A, Liang S, Thomas TL and Klein HL. Discrete gene set depend on POU domain transcription factor BRn3b/Brn-3.2/POU4f2 for their expression in mouse embryonic retina. Development, 2004: 131, 1197-1210. [PMID 14973295] 

Hawes JW, Knudtson KL, Escobar H, Grills GS, Hunter TC, Jackson- Macheslski E, Lin H, Needleman DS, Pershad R, Wiebe GJ. Evaluation of Methods for Sequence Analysis of Highly Repetitive DNA Templates.  J. Biomolecular Techniques, 2006 (2):138-144. [PMID 16741241].

Current/Recent Grant Support

Grant Title: Characterizing moderators of gender differences in recovery from TBI (Niemeier)
Funding Agency: Carolinas Medical Center, Center of Excellence Award
Role: Co Investigator
Years: 2013-2014

Grant Title: AIMS: A Multi-Center, Parallel Group, Randomized, Double-Blind, Placebo-Controlled Trial of Amantadine Hydrochloride in the Treatment of Chronic TBI Irritability and Aggression: A Replication Study.
Funding Agency: National Institute of Disability Rehabilitation & Research
Role: CR- Project Manager 2007-2009, Budget Manager 2010-2013
Years: 2008-2014

Close